The mapping of ovarian cancer mortality trends in Brazil
DOI:
https://doi.org/10.33448/rsd-v9i10.8828Keywords:
Ovarian cancer; Mortality; Trend.Abstract
Ovarian cancer is the eighth cause of death by cancer in women worldwide. The objective of this study was to analyze trends in the Brazilian ovarian cancer mortality and the relation to age, schooling, and race. Data was collected in the Brazilian Mortality Information System (SIM), from 2006 to 2016. The polynomial regression model was used for the trends analysis, a significant trend was considered when the estimated model obtained a p-value <0.05. Ovarian Cancer caused 34,003 deaths in Brazilian women in this period, the mortality rate (MR) was 0.46 per 100.000 women aged less than 40; 4.2 in women aged between 40 – 59; 12.2 in women aged between 60 – 79 and 19.4 in women 80 years old or more. About Race, 65% were White, others were declared as Black, Asian, Mixed-race, or Indigenous. Only 26% had 8 years or more of schooling. Mortality rates from ovarian cancer seemed to be rising in Brazil, the major increase happened in the South, the Southeast, and the Middle-West Regions. Women aged between 40 to 59 had the most significant increase. Politics are needed to facilitate the Brazilian population's access to health services, consequently minimizing the time to diagnose and start the treatment. Research about mortality rates could help health workers identify gaps in knowledge and consequently decrease the magnitude of the disease.
References
Chirlaque, M. D., Uhry, Z., Salmerón, D., Sánchez-Zapata, M. I., Zannoni, G. F., Navarro, C., Verne, J. (2017). Trends in net survival from ovarian cancer in six European Latin countries: Results from the SUDCAN population-based study. European Journal of Cancer Prevention, 26(Trends in cancer net survival in six European Latin Countries: the SUDCAN study), S107–S113. https://doi.org/10.1097/CEJ.0000000000000302
Ervik, M., Lam, F., Ferlay, J., Mery, L., Soerjomataram, I., & Bray, F. (2016). Cancer Today. Retrieved from International Agency for Research on Cancer. Cancer Today. website: http://gco.iarc.fr/today
Grossman, D. C., Curry, S. J., Owens, D. K., Barry, M. J., Davidson, K. W., Doubeni, C. A., Tseng, C. W. (2018). Screening for ovarian cancer US preventive services task force recommendation statement. JAMA - Journal of the American Medical Association, 319(6), 588–594. https://doi.org/10.1001/jama.2017.21926
Henderson, J. T., Webber, E. M., & Sawaya, G. F. (2018). Screening for ovarian cancer updated evidence report and systematic review for the US preventive services task force. JAMA - Journal of the American Medical Association, 319(6), 595–606. https://doi.org/10.1001/jama.2017.21421
International Agency for Research on Cancer. (2019). Cancer Tomorrow. Retrieved from World Health Organization website: https://gco.iarc.fr/tomorrow/graphic-line?type=0&population=900&mode=population&sex=0&cancer=39&age_group=value&apc_male=0&apc_female=0
Keinan-Boker, L., Silverman, B. G., Walsh, P. M., Gavin, A. T., & Hayes, C. (2017). Time trends in the incidence and mortality of ovarian cancer in Ireland, Northern Ireland, and Israel, 1994-2013. International Journal of Gynecological Cancer, 27(8), 1628–1636. https://doi.org/10.1097/IGC.0000000000001079
Landmann-Szwarcwald, C., & Macinko, J. (2016). A panorama of health inequalities in Brazil. International Journal for Equity in Health, 15(1), 1–3. https://doi.org/10.1186/s12939-016-0462-1
Lowe, K. A., Chia, V. M., Taylor, A., O’Malley, C., Kelsh, M., Mohamed, M., … Goff, B. (2013). An international assessment of ovarian cancer incidence and mortality. Gynecologic Oncology, 130(1), 107–114. https://doi.org/10.1016/j.ygyno.2013.03.026
Lowry, K. P., & Lee, S. I. (2017). Imaging and Screening of Ovarian Cancer. Radiologic Clinics of North America, 55(6), 1251–1259. https://doi.org/10.1016/j.rcl.2017.06.010
Malvezzi, M., Carioli, G., Rodriguez, T., Negri, E., & La Vecchia, C. (2016). Global trends and predictions in ovarian cancer mortality. Annals of Oncology, 27(11), 2017–2025. https://doi.org/10.1093/annonc/mdw306
Murthy, N. S., Shalini, S., Suman, G., Pruthvish, S., & Mathew, A. (2009). Changing trends in incidence of ovarian cancer - the Indian scenario. Asian Pacific Journal of Cancer Prevention : APJCP, 10(6), 1025–1030. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20192577
Ojamaa, K., Veerus, P., Baburin, A., Everaus, H., & Innos, K. (2017). Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage. International Journal of Gynecological Cancer, 27(1), 44–49. https://doi.org/10.1097/IGC.0000000000000858
Park, H. K., Ruterbusch, J. J., & Cote, M. L. (2017). Recent trends in ovarian cancer incidence and relative survival in the United States by race/ethnicity and histologic subtypes. Cancer Epidemiology Biomarkers and Prevention, 26(10), 1511–1518. https://doi.org/10.1158/1055-9965.EPI-17-0290
Rocha-brischiliari, S. C., Rosseto, R., Oliveira, D., & Pelloso, S. M. (2017). The Rise in Mortality from Breast Cancer in Young Women : Trend Analysis in Brazil. 1–13. https://doi.org/10.1371/journal.pone.0168950
SEYFERTH, G. (2013). Colonização, Imigração E a Questão Racial No Brasil. Revista USP, 0(53), 117. https://doi.org/10.11606/issn.2316-9036.v0i53p117-149
Sharifian, A., Pourhoseingholi, M. A., Norouzinia, M., & Vahedi, M. (2014). Ovarian cancer in Iranian women, a trend analysis of mortality and incidence. Asian Pacific Journal of Cancer Prevention, 15(24), 10787–10790. https://doi.org/10.7314/APJCP.2014.15.24.10787
Sopik, V., Iqbal, J., Rosen, B., & Narod, S. A. (2015). Why have ovarian cancer mortality rates declined? Part I. Incidence. Gynecologic Oncology, 138(3), 741–749. https://doi.org/10.1016/j.ygyno.2015.06.017
Webb, P. M., Green, A. C., & Jordan, S. J. (2017). Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future. Cancer Causes and Control, 28(5), 365–370. https://doi.org/10.1007/s10552-017-0868-0
Wright, A. A., Bohlke, K., Armstrong, D. K., Bookman, M. A., Cliby, W. A., Coleman, R. L., Edelson, M. I. (2016). Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecologic Oncology, 143(1), 3–15. https://doi.org/10.1016/j.ygyno.2016.05.022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Lander dos Santos; Igor Roszkowski; Amanda de Carvalho Dutra; Adriana Cunha Vargas Tomas; Fernando Castilho Pelloso; Luciano de Andrade; Raissa Bocchi Pedroso; Maria Dalva de Barros Carvalho; Willian Augusto de Melo; Sandra Marisa Pelloso
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
